Ethics Study To Understand The Decision Making Process Of Phase I Cancer Patients
- Determine the range of personality traits of patients enrolled in a phase I clinical
- Determine these patients' understanding of their medical situation and prognosis.
- Determine these patients' understanding of risks and benefits of phase I clinical
- Determine these patients' reasons for participating in a phase I clinical trial.
- Determine the risk/benefit trade-offs of these patients.
- Determine the existential outlook of these patients.
- Determine the information gathering nature of these patients.
OUTLINE: This is a multicenter study.
Before beginning phase I clinical trial treatment, patients complete a survey over 30-45
minutes administered by an interviewer. Patients then self-administer the Temperament and
Character Inventory assessment over 30 minutes.
PROJECTED ACCRUAL: Approximately 250 patients will be accrued for this study within 6
Masking: Open Label
Manish Agrawal, MD
National Cancer Institute (NCI)
|M. D. Anderson Cancer Center at University of Texas||Houston, Texas 77030-4009|
|Robert H. Lurie Comprehensive Cancer Center at Northwestern University||Chicago, Illinois 60611|
|Fox Chase Cancer Center - Philadelphia||Philadelphia, Pennsylvania 19111-2497|
|Cancer Therapy and Research Center||San Antonio, Texas 78229|
|Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office||Bethesda, Maryland 20892-1182|